Total medical devices industry cross border deals worth $545.3m were announced globally for February 2021, with the $108m private equity deal with Mainstay Medical International being the sector’s biggest investment, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 83.9% over the previous month of $3.38bn and a drop of 80.9% when compared with the last 12-month average of $2.86bn.
In terms of number of cross border deals, the sector saw a drop of 7.69% with 36 deals in February 2021 when compared to the last 12-month average of 39 deals.
In value terms, North America led the activity with cross border deals worth $305.47m in February 2021.
Medical Devices industry cross border deals in February 2021: Top deals
The top five cross border deals accounted for 66.1% of the overall value during February 2021.
The combined value of the top five cross border deals stood at $360.67m, against the overall value of $545.3m recorded for the month.
The top five medical devices industry cross border deals of February 2021 tracked by GlobalData were:
4) The $54.67m private equity deal of MaxCyte by ArrowMark Partners, Baron Capital Management, Casdin Capital, D1 Capital Partners, First Light Asset Management, Sofinnova Partners and T. Rowe Price Group